There is no single “best” medication for OCD, but SSRIs are the clear first-line choice, and they work for roughly 40 to 60 percent of people who try them. Five medications carry FDA approval specifically for OCD: fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil), and clomipramine (Anafranil). All of them work by increasing serotonin activity in the brain, and no one SSRI has proven consistently superior to the others. The “best” one for you depends on your side effect tolerance, other medications you take, and how your body responds.
SSRIs Are the Standard Starting Point
SSRIs are recommended as first-line medication for OCD by every major psychiatric guideline, alongside cognitive-behavioral therapy. Unlike their use in depression, where a standard dose often does the job, OCD typically requires higher doses and longer timelines. Benefit usually becomes noticeable around six to eight weeks, and a full trial of 10 to 12 weeks at the maximum comfortably tolerated dose is necessary before deciding whether a particular SSRI is working.
That dosing difference catches many people off guard. Sertraline, for example, is commonly prescribed at 50 to 200 mg for depression, but OCD specialists routinely push it to 400 mg. This pattern holds across the SSRI class: the doses needed for meaningful OCD relief are often well above the standard ranges listed for other conditions. The FDA does not prohibit these higher doses, and evidence suggests that higher SSRI doses produce somewhat better response rates and greater symptom relief.
None of the four SSRIs approved for OCD consistently outperforms the others in head-to-head trials. In practice, the choice often comes down to practical factors. Fluoxetine has a very long half-life, which makes missed doses less disruptive. Sertraline has relatively few drug interactions. Fluvoxamine tends to be slightly more sedating, which can help if anxiety or insomnia is prominent. If one SSRI doesn’t work after a full trial, switching to a different one is a reasonable next step, because people who don’t respond to one may still respond to another.
Clomipramine: More Effective but Harder to Tolerate
Clomipramine is technically the most effective single medication for OCD. A large meta-analysis published in BMJ Mental Health found that even after correcting for study quality and bias, clomipramine produced significantly larger symptom reductions than SSRIs. It was the first drug proven to work for OCD, and it remains a powerful option.
The catch is its side effect profile. Clomipramine is a tricyclic antidepressant, not a true SSRI, and it affects more systems in the body. It commonly causes dry mouth, constipation, weight gain, drowsiness, and sexual side effects at higher rates than SSRIs. It also carries risks of cardiac side effects and can be dangerous in overdose, which is why it’s typically reserved for people who haven’t responded to at least one or two SSRI trials. If you can tolerate it, though, clomipramine is one of the most potent tools available.
How Response Is Measured
Clinicians track OCD medication response using a standardized questionnaire called the Y-BOCS, which scores symptom severity from 0 to 40. A “response” to treatment means at least a 30 to 35 percent reduction in that score. Full “remission” means the score drops to 12 to 15 or below, a level where OCD symptoms are mild enough that they no longer significantly interfere with daily life.
These benchmarks matter because OCD medication rarely eliminates symptoms entirely. A successful trial typically means obsessions become less intense and less frequent, compulsions become easier to resist, and the amount of time consumed by OCD drops substantially. Many people notice they can function well even with some residual symptoms, especially when medication is combined with therapy.
When the First Medications Don’t Work
About 40 to 60 percent of people with OCD don’t get an adequate response from their first SSRI. After trying two or three SSRIs (or clomipramine), the next step is usually augmentation, meaning adding a second medication on top of the SSRI rather than replacing it.
The most studied augmentation strategy is adding a low-dose antipsychotic. Aripiprazole has the strongest evidence here, with studies showing an average Y-BOCS reduction of about 5 to 7 points on top of whatever the SSRI achieved. One study found a response rate of 80 percent with aripiprazole augmentation, though other trials have been more modest, with around 30 percent of patients responding. Risperidone has also shown benefit, though with a somewhat smaller effect. Newer agents like brexpiprazole and cariprazine are showing early promise, with response rates of roughly 50 to 60 percent in preliminary studies.
These antipsychotics are used at much lower doses for OCD augmentation than they would be for conditions like schizophrenia, which keeps side effects more manageable. Still, they can cause weight gain, fatigue, and metabolic changes, so they’re reserved for cases where SSRIs alone aren’t enough.
OCD Medication in Children and Teens
Four medications carry FDA approval for pediatric OCD, each with a different minimum age: sertraline (age 6 and up), fluoxetine (age 7 and up), fluvoxamine (age 8 and up), and clomipramine (age 10 and up). The same principles apply as in adults. Higher doses are often needed compared to depression treatment, and a full trial takes 10 to 12 weeks. Cognitive-behavioral therapy is considered especially important in younger patients and is often tried first or alongside medication.
Why OCD Medication Takes So Long to Work
One of the most frustrating aspects of OCD treatment is the timeline. While antidepressants for depression may start showing effects in two to four weeks, OCD medications typically need six to eight weeks before any benefit is noticeable. A full 10 to 12 weeks at the highest dose you can comfortably tolerate is the standard recommendation before concluding that a medication isn’t working.
This means a single medication trial can take three months or more, including the time to gradually increase the dose. If the first medication doesn’t work, a second trial adds another three months. People who end up needing augmentation may spend six to nine months finding the right combination. This is normal for OCD treatment and doesn’t mean the medications aren’t effective. It means the brain changes they produce build gradually.
Medication vs. Therapy, or Both
Cognitive-behavioral therapy, specifically a technique called exposure and response prevention, is considered equally effective to medication for OCD and is recommended as a first-line treatment alongside SSRIs. The combination of both tends to produce the best outcomes. Medication can lower symptom intensity enough that therapy becomes more manageable, and therapy builds skills that help sustain improvement if medication is eventually tapered.
For mild to moderate OCD, therapy alone is a reasonable starting point. For moderate to severe cases, starting both at the same time is common. Medication alone is an option when therapy isn’t accessible, though the relapse rate after stopping medication is higher without therapy skills in place. Most people who respond well to medication need to stay on it for at least one to two years, and many continue long-term.